New Strong Sell Stocks for January 8th

AZTA, BCBP and CLCO have been added to the Zacks Rank #5 (Strong Sell) List on January 8th, 2026.

Zacks Investment Research • Jan 8, 2026

New Strong Sell Stocks for December 30th

ASBFY, AZTA and ALG have been added to the Zacks Rank #5 (Strong Sell) List on December 30, 2025.

Zacks Investment Research • Dec 30, 2025

Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.À R.L.

BURLINGTON, Mass. , Dec. 29, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that its affiliate, Azenta Germany GmbH, has signed a binding agreement for the sale of Azenta's B Medical Systems business to THELEMA S.

PRNewsWire • Dec 29, 2025

New Strong Sell Stocks for Dec. 15

ALG, AZTA and CMG have been added to the Zacks Rank #5 (Strong Sell) List on Dec. 15, 2025.

Zacks Investment Research • Dec 15, 2025

Azenta, Inc. (AZTA) Analyst/Investor Day Transcript

Azenta, Inc. (AZTA) Analyst/Investor Day Transcript

Seeking Alpha • Dec 11, 2025

Azenta Authorizes $250 Million Share Repurchase Program

BURLINGTON, Mass. , Dec. 10, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that its Board of Directors has approved a share repurchase program under which the company may repurchase up to $250 million of its outstanding common stock.

PRNewsWire • Dec 10, 2025

New Strong Sell Stocks for December 9th

BRBR, AZTA and BRDCY have been added to the Zacks Rank #5 (Strong Sell) List on December 9, 2025.

Zacks Investment Research • Dec 9, 2025

Why a $5 Million Bet on Azenta Could Pay Off After a 70% Stock Slide

Dallas-based Meros Investment Management purchased 159,945 shares of Azenta valued at $4.6 million in the third quarter. The position represents 2% of Meros's 13F reportable assets under management.

The Motley Fool • Dec 8, 2025

Azenta, Inc. (AZTA) Q4 2025 Earnings Call Transcript

Azenta, Inc. ( AZTA ) Q4 2025 Earnings Call November 21, 2025 8:30 AM EST Company Participants Yvonne Perron - Vice President of Financial Planning & Analysis and Investor Relations John P. Marotta - President, CEO & Director Lawrence Lin - Executive VP & CFO Conference Call Participants David Saxon - Needham & Company, LLC, Research Division Steven Etoch - Stephens Inc., Research Division Andrew Cooper - Raymond James & Associates, Inc., Research Division Vijay Kumar - Evercore ISI Institutional Equities, Research Division Jacqueline Kisa - TD Cowen, Research Division Paul Knight - KeyBanc Capital Markets Inc., Research Division Presentation Operator Greetings, and welcome to the Azenta Q4 2025 Financial Results.

Seeking Alpha • Nov 21, 2025

Azenta Reports Fourth Quarter and Full Year Fiscal 2025 Results, Ended September 30, 2025

Q4'25 reported revenue growth of 6% year over year and 4% on an organic basis FY'25 reported revenue growth of 4% and 3% on an organic basis FY'25 Adjusted EBITDA margin expansion of 310 basis points versus last year FY'26 organic revenue growth expected to be 3% to 5% year over year, with Adjusted EBITDA margin expansion of approximately 300 basis points BURLINGTON, Mass. , Nov. 21, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the fourth quarter and fiscal year ended September 30, 2025.

PRNewsWire • Nov 21, 2025